Functional Skills
Business Analysis
Business Development
Financial Modeling
Valuation
Business Unit Strategy
Commercial Due Diligence
Investment Banking
Competitive Landscaping
Market Research
Market Intelligence
Private Equity Investing
Software Skills
Microsoft Excel
Microsoft PowerPoint
Sector Experience
Financial Services
Healthcare
Life Sciences & Pharma
Languages
English
Countries Worked In
USCase Study
Case Studies

Valuation and SPAC Advisory for $3.5B de-SPAC Transaction in the Genomics Sector
Life Sciences & Pharma
Valuation
Investment Banking
Growth Strategy

Commercial Due Diligence Support for $10B Dermatology Platform Acquisition
Life Sciences & Pharma
Financial Modeling
Commercial Due Diligence
Market Research

Post-Merger Portfolio Optimization for Global Biopharma Across Immunology & Oncology
Life Sciences & Pharma
Portfolio Optimization
Commercial Due Diligence

Investment Thesis and Opportunity Analysis for Healthcare Focused Private Equity Firm
Life Sciences & Pharma
Commercial Due Diligence
Valuation
Competitive Landscaping

SPAC Merger Advisory and Valuation Support for Oncology Biotech Transaction
Life Sciences & Pharma
Variance Analysis
Market Research
Notable Clients
Bristol-Myers Squibb
EQT
Johnson & Johnson
Merck
Big 3 Consulting (MBB)
Bulge Bracket Investment Banks
Top Consulting Firms
Experience
Firedance Capital
Finance
Founder & Principal Consultant
5/2024 - Present
• Founded investment research advisory focused on public equities and digital assets.
• Produced macro and thematic insights to guide portfolio strategy and risk management.
• Produced macro and thematic insights to guide portfolio strategy and risk management.
MTS Health Partners
Finance
Vice President, Healthcare Investment Banking
9/2022 - 4/2024
• Led execution of biopharma M&A, strategic partnerships, and licensing transactions.
• Structured NPV models to guide monetization strategies (e.g., ex-US licensing) and developed term sheet economics in collaboration with BD and executive leadership.
• Structured NPV models to guide monetization strategies (e.g., ex-US licensing) and developed term sheet economics in collaboration with BD and executive leadership.
Credit Suisse
Finance
Senior Associate / Vice President, Healthcare Investment Banking
11/2020 - 8/2022
• Executed IPOs, de-SPACs, and follow-ons for biotech and life sciences tools companies.
• Built DCF, SOTP, and SPAC valuation models; supported S-1 drafting and due diligence processes.
• Built DCF, SOTP, and SPAC valuation models; supported S-1 drafting and due diligence processes.
McKinsey & Company
Management Consulting
Junior Engagement Manager, Pharmaceutical and Medical Products
7/2017 - 9/2020
• Led diligence and growth strategy for biopharma, healthcare services, and life sciences tools/diagnostics, including Millipore Sigma, Janssen, Shields Health, and Merck.